Multi-omics profiling of PC-3 cells reveals bufadienolides-induced lipid metabolic remodeling by regulating long-chain lipids synthesis and hydrolysis
- PMID: 36645548
- DOI: 10.1007/s11306-022-01968-7
Multi-omics profiling of PC-3 cells reveals bufadienolides-induced lipid metabolic remodeling by regulating long-chain lipids synthesis and hydrolysis
Abstract
Introduction: Lipid metabolism participates in various biological processes such as proliferation, apoptosis, migration, invasion, and maintenance of membrane homeostasis of prostate tumor cells. Bufadienolides, the active ingredients of Chansu, show a robust anti-proliferative effect against prostate cancer cells in vitro, but whether bufadienolides could regulate the lipid metabolism in prostate cancer has not been evaluated.
Objectives: Our study explored the regulatory effects of bufadienolides on lipid metabolism in human prostate carcinoma cells (PC-3).
Methods: Untargeted lipidomics and transcriptomics were combined to study the effect of different bufadienolides interventions on lipid and gene changes of PC-3 cells. The key genes related to lipid metabolism and prostate cancer development were verified by qPCR and western blotting.
Results: Lipidomic analysis showed that the active bufadienolides significantly downregulated the content of long-chain lipids of PC-3 cells. Based on transcriptomic and qPCR analyses, many genes related to lipid metabolism were significantly regulated by active bufadienolides, such as ELOVL6, CYP2E1, GAL3ST1, CERS1, PLA2G10, PLD1, SPTLC3, and GPX2. Bioinformatics analysis of the Cancer Genome Atlas database and literature retrieval showed that elongation of very long-chain fatty acids protein 6 (ELOVL6) and phospholipase D1 (PLD1) might be important regulatory genes. Western blot analysis revealed that active bufadienolides could downregulate PLD1 protein levels which might promote anti-prostate cancer effect.
Conclusions: All these findings support that bufadienolides might induce lipid metabolic remodeling by regulating long-chain lipids synthesis and phospholipid hydrolysis to achieve an anti-prostate cancer effect, and PLD1 would probably be the key protein.
Keywords: Bufadienolides; ELOVL6; Lipidomics; PLD1; Prostate cancer; Transcriptomics.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Multi-omics reveals bufadienolide Q-markers of Bufonis Venenum based on antitumor activity and cardiovascular toxicity in zebrafish.Phytomedicine. 2024 Oct;133:155914. doi: 10.1016/j.phymed.2024.155914. Epub 2024 Aug 5. Phytomedicine. 2024. PMID: 39121534
-
The lipidomic profile of the tumoral periprostatic adipose tissue reveals alterations in tumor cell's metabolic crosstalk.BMC Med. 2022 Aug 18;20(1):255. doi: 10.1186/s12916-022-02457-3. BMC Med. 2022. PMID: 35978404 Free PMC article.
-
Metabolomics and transcriptomics based multi-omics integration reveals radiation-induced altered pathway networking and underlying mechanism.NPJ Syst Biol Appl. 2023 Sep 9;9(1):42. doi: 10.1038/s41540-023-00305-5. NPJ Syst Biol Appl. 2023. PMID: 37689794 Free PMC article.
-
New insights into lipid metabolism and prostate cancer (Review).Int J Oncol. 2023 Jun;62(6):74. doi: 10.3892/ijo.2023.5522. Epub 2023 May 19. Int J Oncol. 2023. PMID: 37203395 Free PMC article. Review.
-
Bufadienolides from amphibians: A promising source of anticancer prototypes for radical innovation, apoptosis triggering and Na+/K+-ATPase inhibition.Toxicon. 2017 Mar 1;127:63-76. doi: 10.1016/j.toxicon.2017.01.004. Epub 2017 Jan 7. Toxicon. 2017. PMID: 28069354 Review.
Cited by
-
TransGEM: a molecule generation model based on Transformer with gene expression data.Bioinformatics. 2024 May 2;40(5):btae189. doi: 10.1093/bioinformatics/btae189. Bioinformatics. 2024. PMID: 38632084 Free PMC article.
References
-
- Attard, G., Parker, C., Eeles, R. A., Schröder, F., Tomlins, S. A., Tannock, I., Drake, C. G., & de Bono, J. S. (2016). Prostate cancer. The Lancet, 387(10013), 70–82. https://doi.org/10.1016/s0140-6736(14)61947-4 - DOI
-
- Berger, A. C., Korkut, A., Kanchi, R. S., Hegde, A. M., Lenoir, W., Liu, W., Liu, Y., Fan, H., Shen, H., Ravikumar, V., Rao, A., Schultz, A., Li, X., Sumazin, P., Williams, C., Mestdagh, P., Gunaratne, P. H., Yau, C., Bowlby, R., et al. (2018). A Comprehensive pan-cancer molecular study of gynecologic and breast cancers. Cancer Cell, 33(4), 690–705. https://doi.org/10.1016/j.ccell.2018.03.014 - DOI - PubMed - PMC
-
- Bowling, F. Z., Salazar, C. M., Bell, J. A., Huq, T. S., Frohman, M. A., & Airola, M. V. (2020). Crystal structure of human PLD1 provides insight into activation by PI(4,5)P2 and RhoA. Nature Chemical Biology, 16(4), 400–407. https://doi.org/10.1038/s41589-020-0499-8 - DOI - PubMed - PMC
-
- Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492 - DOI - PubMed
-
- Brigelius-Flohe, R., & Flohe, L. (2020). Regulatory Phenomena in the Glutathione Peroxidase Superfamily. Antioxidants & Redox Signaling, 33(7), 498–516. https://doi.org/10.1089/ars.2019.7905 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical